Biovail Accuses Elan, Fournier Of Misleading USPTO
Biovail Corp. has fired back in a lawsuit over its generic formulation of cholesterol treatment TriCor, alleging that the patents for TriCor owned by Elan Pharma International Ltd. and Fournier Laboratories...To view the full article, register now.
Already a subscriber? Click here to view full article